Medication info
Jardiance Duo Tablet 5/1000 mg

Jardiance Duo Tablet 5/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›5mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Boehringer Ingelheim Korea
Appearance
Brownish-yellow, bilaterally convex oval film-coated tablet
Packaging
60 tablets/box [10 tablets/PTP×6]
Approval status
Active

MFDS item code 201600387 · Approved 2016.01.21 · Insurance code 653501500

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medication is 1 tablet per dose, 2 times daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medications such as insulin, the recommended dose is empagliflozin 5 mg 2 times daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medication from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medication is administered concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use 4. Adverse Reactions and 6. Interactions). This medication should be taken with meals to reduce gastrointestinal adverse effects associated with metformin. If a dose of this medication is missed, take it as soon as remembered. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medication contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medication is 1000 mg, given as 500 mg 2 times daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, discontinue this medication immediately (see Precautions for Use 2. Patients in Whom This Medication Is Contraindicated, item 2)). Elderly patients In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.

Ingredients

Importer
Boehringer Ingelheim Korea

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Blood sugar control issues in adult patients with type 2 diabetes
  • cardiovascular disease
  • risk of cardiovascular events
View approved original text

This medication is used as an adjunct to diet and exercise to improve blood sugar control in adult patients with type 2 diabetes. Particularly when blood sugar is not adequately controlled, the combination of empagliflozin and metformin may enhance effectiveness. It is also used in patients with cardiovascular disease, and caution regarding the occurrence of cardiovascular events must be referenced. This medication is effective in improving blood sugar control and assisting in diabetes management.

How to take

Adult dose

The recommended dose of this medication is 1 tablet per dose, 2 times daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medications such as insulin, the recommended dose is empagliflozin 5 mg 2 times daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medication from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medication is administered concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use 4. Adverse Reactions and 6. Interactions). This medication should be taken with meals to reduce gastrointestinal adverse effects associated with metformin. If a dose of this medication is missed, take it as soon as remembered. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medication contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medication is 1000 mg, given as 500 mg 2 times daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, discontinue this medication immediately (see Precautions for Use 2. Patients in Whom This Medication Is Contraindicated, item 2)). Elderly patients In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.

Precautions

This medication is a diabetes treatment that helps control blood sugar. Note that while taking this medication, there is a risk of a rare but serious adverse effect called lactic acidosis. Lactic acidosis is a condition where lactic acid builds up in the body excessively, which can be life-threatening in severe cases. Additionally, there is a risk of hypoglycemia when taken with other diabetes medications such as insulin or sulfonylureas, so blood sugar levels should be closely monitored. This medication should not be used in patients with impaired kidney function or serious conditions such as acute kidney problems, heart failure, or acute myocardial infarction. Before and after tests using radiocontrast agents with iodine, this medication should be temporarily discontinued, and can be resumed only after kidney function has been confirmed as normal. If health conditions change during treatment, such as fluid loss, infections, dehydration, liver dysfunction, or poor nutritional status, consult healthcare providers immediately. This medication may increase the risk of urinary tract infections or genital infections, so prompt treatment is warranted if symptoms of infection appear. There is also a risk of vitamin B12 deficiency, so it is advisable to regularly monitor serum vitamin B12 levels during long-term use. Women who are pregnant or may become pregnant, as well as breastfeeding women, should not take this medication, and it is not recommended for children as safety has not been established. Elderly patients may experience reduced kidney function, so regular kidney function tests are necessary, and dosage adjustments may be needed. In case of overdose, serious adverse effects such as lactic acidosis may occur, requiring immediate hospital treatment, and blood dialysis may be needed. When storing this medication, keep it out of reach of children and store it in its original container for safety. Finally, it is important to regularly check health status while taking this medication and consult a physician immediately if any abnormal symptoms occur.

Side effects

  • Severe lactic acidosis
  • hypoglycemia
  • urinary tract infection
  • genital infection
  • increased urination
  • reduced vitamin B12 and deficiency
  • ketoacidosis
  • nausea
  • vomiting
  • diarrhea
Show 159 more
  • abdominal pain
  • loss of appetite
  • constipation
  • abnormal liver function tests
  • hepatitis
  • altered taste
  • itching
  • rash
  • urticaria
  • erythema
  • angioedema
  • dysuria
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • elevated blood creatinine
  • decreased glomerular filtration rate
  • necrotizing fasciitis of the perineum
  • urosepsis
  • pyelonephritis
  • vaginal mycosis
  • vulvitis
  • balanitis
  • hypoglycemia
  • hypotension
  • dehydration
  • low blood pressure
  • decreased blood volume
  • orthostatic hypotension
  • syncope
  • elevated blood creatinine
  • decreased glomerular filtration rate
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • bowel hemorrhage
  • chronic gastritis
  • constipation
  • gastritis
  • abdominal discomfort
  • anal incontinence
  • dry mouth
  • gastrointestinal disturbance
  • gastroesophageal reflux disease
  • oral discomfort
  • salivary gland pain
  • headache
  • sensory loss
  • postural dizziness
  • cerebral infarction
  • soft tissue infection
  • pneumonia
  • ankle fracture
  • epicondylitis
  • facial bone fracture
  • musculoskeletal pain
  • myocardial infarction
  • pancreatic carcinoma
  • insomnia
  • dizziness
  • nasopharyngitis
  • herpes zoster
  • chest discomfort
  • chest pain
  • weakness
  • weight loss
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • hyperglycemia
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • diabetic foot
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • glaucoma
  • macular fibrosis
  • eye discomfort
  • eye congestion
  • pathological myopia
  • retinal detachment
  • retinal crystals
  • retinal vein occlusion
  • exudative retinal detachment
  • eyelid edema
  • visual disturbance
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • productive cough
  • allergic rhinitis
  • residual phlegm
  • cough
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina
  • palpitations
  • Prinzmetal angina
  • coronary artery disease
  • tachycardia
  • arteriosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral artery occlusive disease
  • anxiety
  • depression
  • sleep disturbances
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • hepatitis
  • otalgia
  • positional vertigo
  • vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • diabetic retinopathy
  • dry eyes
  • dyspnea
  • unstable angina
  • hypertension

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture, and ideally kept at room temperature between 1 and 30 degrees Celsius. This storage method helps to maintain the effectiveness and safety of the medication.

Appearance and packaging

Appearance

Brownish-yellow, bilaterally convex oval film-coated tablet

Package unit

60 tablets/box [10 tablets/PTP×6]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.